Attenuation of NF-κB signaling pathway by ATO was shown also in a study from Nasrollahzadeh et al. This ATO effect was synergistically potentiated by BIBR1532, an inhibitor of hTERT, leading to attenuation of breast cancer cell proliferation [59]. Here, NFKB1 is linked to breast cancer.